U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166107) titled 'EVOLV-Rx VA: Evaluating Opportunities to Decrease Low-Value Prescribing in Community Living Centers' on Sept. 02.
Brief Summary: The investigators developed EVOLV-Rx (Evaluating Opportunities to Decrease Low-Value Prescribing), a novel clinical support tool to detect 18 evidence-based and clinically useful low-value prescribing practices in older adults. The objective is to conduct a hybrid study to assess the effectiveness and implementation of an EVOLV-Rx-based intervention to reduce LVP among older Veterans who reside in CLCs in VISN 4.
In Aim 1, the investigators will conduct focus groups of VISN 4 CLC leaders, clinicians, Vet...